Clinical Trial Update: Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial completed to assess the efficacy and tolerability of fimasartan in mild-to-moderate essential hypertension and to determine the optimal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension | Phase 2 | Status: COMPLETED